European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Chemical

Merck Completes Acquisition of Exelead and Plans to Invest More Than € 500 Million in Technology Scale-Up

by Marie Weil
February 24, 2022
A A
Share on LinkedinShare on Twitter

Merck today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash.

  • Continued investment in Exelead’s capabilities planned over the next ten years
  • Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
  • Company now offers comprehensive end-to-end services across mRNA value chain

Merck, a leading science and technology company, today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash. The business combination is expected to enable Merck’s Life Science business sector to provide its customers with comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain. Merck plans to further invest over € 500 million to scale up Exelead’s technology over the next ten years.

“With the addition of Exelead’s leading capabilities and highly experienced team, Merck achieves an important milestone in becoming one of the leading CDMO players in mRNA vaccines and therapeutics, offering an integrated CDMO across the mRNA value chain from pre-clinical to commercial,” said Matthias Heinzel, Member of the Executive Board of Merck and CEO Life Science. “mRNA holds much promise as a treatment well beyond Covid-19 and we will further invest in this technology to help realize its potential.”

Exelead, a biopharmaceutical CDMO, specializes in PEGylated products and complex injectable formulations, including Lipid Nanoparticle (LNP) based drug delivery technology, which is key in mRNA vaccines and therapeutics for use in Covid-19 and many other indications. The company has experience in all development phases from pre-clinical development to commercial contract manufacturing for LNP formulations, including fill and finish. Exelead will complement Merck’s more than 20 years’ experience in producing lipids as well as its mRNA manufacturing capabilities acquired through AmpTec in 2020. This integrated offering will accelerate Merck’s ability to bring life-enhancing vaccines and treatments to patients faster by simplifying supply chain complexity and enhancing speed to market through its end-to-end portfolio.

Over the past two years, Merck’s Life Science business sector has made significant investments to advance traditional and novel modalities (mAb, ADC, HP-API, viral vector, and mRNA) through acquisitions and expansions. The acquisition of Exelead is another milestone to accelerate innovation in Merck’s Process Solutions and Life Science Services businesses, one of the company’s three growth engines (“Big 3”), through targeted smaller to medium-sized acquisitions with high impact.

Tags: < Invest<< HIGHLIGHTS

Related Industries

Chemical

Dominik Risse takes over as head of LANXESS Urethane Systems Business Unit

February 25, 2023
Chemical

BASF and Tenova Advanced Technologies enter into a joint development agreement for efficient recycling of lithium-ion batteries

February 23, 2023
Chemical

UPM Biochemicals and HAERTOL Chemie GmbH announce strategic partnership to develop new sustainable coolants

February 10, 2023
Chemical

Bill Anderson to become CEO of Bayer AG

February 9, 2023
Chemical

MIDO Eyewear show: Arkema to showcase its innovations in Advances bio-circular materials

January 31, 2023
Chemical

Henkel highlights pad printing and antenna technologies at LOPEC 2023

January 26, 2023

Bayer driving innovation in radiology with new research across the portfolio presented at ECR

February 23, 2023

...

Deutsche Post DHL Group and Poste Italiane announce a strategic partnership in the international parcel market

March 11, 2023

...

Henkel launches novel Sensor INKxperience Kit for IOT sensor engineering with printed electronics technologies

February 23, 2023

...

Thierry Koskas Is Appointed Citroën Brand CEO and Stellantis Chief Sales & Marketing Officer

February 24, 2023

...

ABB invests in Direct Current microgrid start-up Direct Energy Partners to accelerate energy transformation

March 9, 2023

...

Change in top management at Lufthansa Group and Lufthansa Airlines

February 23, 2023

...

Dominik Risse takes over as head of LANXESS Urethane Systems Business Unit

February 25, 2023

...

Carrier Makes Donation to the European Food Banks Federation to Help Reduce Food Insecurity in Europe

March 8, 2023

...

ELC Partners with boom! to Empower Women in Supply Chain in the UK and Worldwide

March 7, 2023

...

Introducing the Aygo X UNDERCOVER

March 3, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist